Any Orthopaedic condition which would require ankle or hind foot surgery under Mr. James Calder at North Hampshire Hospital, Basingstoke.
Conditions
Interventions
Product Name: Bupivacaine 0.25%
Pharmaceutical Form: Solution for infusion
Pharmaceutical form of the placebo: Solution for infusion
Route of administra
Sponsors
North Hampshire Hospital NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients listed for ankle and hindfoot surgery under Mr. James Calder. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Peripheral neuropathy Inability to fill in questionnaires (e.g. dementia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Secondary Objective: We will also be assessing whether the infusion regime alters the time to mobilise, time to discharge, the supplemental oral analgesia intake and the overall patient satisfaction.;Primary end point(s): Pain relief as assessed by visual analogue scores over 72 hours post-operatively.;Main Objective: To assess pain relief in foot and ankle surgery. This will be acheived analysing the results of a randomised, prospective, double blinded, placebo controlled trail comparing the effectiveness of a single bolus peroneal and tibial nerve block against a bolus and continuous infusion peroneal and tibial nerve block in the management of post operative pain following foot and ankle surgery. | — |
Countries
United Kingdom
Outcome results
None listed